Sequana, Memorial Sloan-Kettering Cancer Center deal

SQNA and Sloan-Kettering formed a joint venture to identify genes that will be of value in the prognosis, diagnosis and treatment of common cancers (see Noteworthy, BioCentury Part I). The joint ventu...